Manager, Regulatory Affairs
Noctrix Health
Manager, Regulatory Affairs
Noctrix Health
Prescription wearable neuromodulation for RLS.
Noctrix Health is redefining the treatment of chronic neurological disorders with clinically validated therapeutic wearables. Our team of medical device specialists, neuroscientists, and consumer electronics engineers is dedicated to delivering prescription-grade therapy with an outstanding user experience. We have pioneered the world’s first drug-free wearable therapy, clinically proven to alleviate symptoms in adults with drug-resistant Restless Legs Syndrome (RLS). Join us in transforming healthcare, improving lives, and driving meaningful change through innovative medical technology.
We are seeking an experienced and highly organized Manager, Regulatory Affairs to lead and execute regulatory activities supporting the development, registration, commercialization, and post-market compliance of Noctrix Health’s medical devices. This role will help ensure regulatory strategies and deliverables are executed accurately, compliantly, and on schedule throughout the product lifecycle.
The Manager, Regulatory Affairs will work closely with Clinical Affairs, Quality, Engineering, Operations, Marketing, and external regulatory partners to provide regulatory guidance, manage submissions, assess product changes, maintain global registrations, and support post-market regulatory activities. The ideal candidate combines strong medical device regulatory expertise with excellent project management skills and the ability to independently drive complex regulatory initiatives across multiple functions.
This position reports to the Senior Vice President, Clinical & Regulatory Affairs.
This is a full-time, hybrid position that is located at our Pleasanton headquarters.
Responsibilities:
Requirements:
Preferred Qualifications:
Compensation:
Prescription wearable neuromodulation for RLS.
Noctrix Health develops a prescription wearable that treats restless legs syndrome through non-pharmacologic neuromodulation. Its NTX100 TOMAC System (Nidra) uses leg bands to stimulate the peroneal nerves at night, producing gentle muscle activation to suppress RLS sensations and improve sleep. It differentiates itself with a clinically validated, prescription-based approach backed by an FDA De Novo clearance after a Breakthrough designation, plus roots in Stanford Biodesign. The goal is to make wearable therapeutics a standard, non-drug option for patients who do not respond to or cannot tolerate medications.
Explore more opportunities at Noctrix Health